Insulin Resistance in Nonalcoholic Fatty Liver Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|16|17|1941-1951

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.17, 2010-06, pp. : 1941-1951

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nonalcoholic fatty liver disease: a review

By Poordad F Fred  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 3, 2005-08 ,pp. : 661-670

Informa Healthcare

Access to resources Recommend Favorite

Nonalcoholic Fatty Liver Disease and Cardiovascular Disease

By  

Current Pharmaceutical Design, Vol. 20, Iss. 14, 2014-04 ,pp. : 2403-2411

Bentham Science Publishers

Access to resources Recommend Favorite

Current treatment for nonalcoholic fatty liver disease

By Katsiki Niki   Athyros Vasilios G   Karagiannis Asterios   Mikhailidis Dimitri P  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 13, 2011-09 ,pp. : 2141-2142

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs for non-alcoholic fatty liver disease

By Federico Alessandro   Niosi Marco   Vecchio Blanco Camillo Del   Loguercio Carmela  

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 1, 2008-03 ,pp. : 145-158

Informa Healthcare

Access to resources Recommend Favorite

Novel therapeutic targets for nonalcoholic fatty liver disease

By Eguchi Akiko  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 7, 2013-10 ,pp. : 773-779

Informa Healthcare

Access to resources Recommend Favorite